Stefan Rydén

764 total citations
18 papers, 586 citations indexed

About

Stefan Rydén is a scholar working on Oncology, Cancer Research and Economics and Econometrics. According to data from OpenAlex, Stefan Rydén has authored 18 papers receiving a total of 586 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 5 papers in Cancer Research and 4 papers in Economics and Econometrics. Recurrent topics in Stefan Rydén's work include Breast Cancer Treatment Studies (5 papers), Global Cancer Incidence and Screening (4 papers) and HER2/EGFR in Cancer Research (4 papers). Stefan Rydén is often cited by papers focused on Breast Cancer Treatment Studies (5 papers), Global Cancer Incidence and Screening (4 papers) and HER2/EGFR in Cancer Research (4 papers). Stefan Rydén collaborates with scholars based in Sweden, United States and Denmark. Stefan Rydén's co-authors include D. Killander, Åke Borg, Helgi Sigurðsson, Håkan Olsson, Mårten Fernö, Henrik Møller, Larsolof Hafström, Lennart Bergqvist, Sven‐Erik Strand and Nils Bjurstam and has published in prestigious journals such as Journal of Hepatology, European Journal of Cancer and Cancer Letters.

In The Last Decade

Stefan Rydén

18 papers receiving 567 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stefan Rydén Sweden 11 366 210 140 116 107 18 586
Jørn Andersen Denmark 20 461 1.3× 285 1.4× 181 1.3× 103 0.9× 165 1.5× 36 1.0k
Jane E. Brock United States 16 369 1.0× 315 1.5× 62 0.4× 85 0.7× 85 0.8× 42 727
Xiao-Ming Xie China 14 386 1.1× 260 1.2× 53 0.4× 65 0.6× 90 0.8× 22 629
R Gray United States 10 445 1.2× 313 1.5× 156 1.1× 28 0.2× 186 1.7× 15 732
D Perrault Canada 11 382 1.0× 162 0.8× 109 0.8× 34 0.3× 56 0.5× 16 610
Jaume Capdevila Spain 18 277 0.8× 59 0.3× 150 1.1× 101 0.9× 150 1.4× 41 1.0k
Johanna Wassermann France 12 197 0.5× 98 0.5× 42 0.3× 90 0.8× 77 0.7× 41 514
JN Atkins United States 11 303 0.8× 143 0.7× 50 0.4× 41 0.4× 117 1.1× 22 500
Hagen Kennecke Canada 9 248 0.7× 127 0.6× 31 0.2× 48 0.4× 75 0.7× 14 398
P C Allgood United Kingdom 15 603 1.6× 200 1.0× 82 0.6× 72 0.6× 22 0.2× 21 833

Countries citing papers authored by Stefan Rydén

Since Specialization
Citations

This map shows the geographic impact of Stefan Rydén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Rydén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Rydén more than expected).

Fields of papers citing papers by Stefan Rydén

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefan Rydén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Rydén. The network helps show where Stefan Rydén may publish in the future.

Co-authorship network of co-authors of Stefan Rydén

This figure shows the co-authorship network connecting the top 25 collaborators of Stefan Rydén. A scholar is included among the top collaborators of Stefan Rydén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefan Rydén. Stefan Rydén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Stenman, Emelie, et al.. (2021). Diagnostic center for primary care patients with nonspecific symptoms and suspected cancer: compliance to workflow and accuracy of tests and examinations. Scandinavian Journal of Primary Health Care. 39(2). 148–156. 2 indexed citations
2.
3.
Stenman, Emelie, Karolina Palmér, Stefan Rydén, et al.. (2019). Diagnostic spectrum and time intervals in Sweden’s first diagnostic center for patients with nonspecific symptoms of cancer. Acta Oncologica. 58(3). 296–305. 19 indexed citations
4.
Anell, Anders, Oskar Hagberg, Fredrik Liedberg, & Stefan Rydén. (2016). A randomized comparison between league tables and funnel plots to inform health care decision-making. International Journal for Quality in Health Care. 28(6). 816–823. 7 indexed citations
5.
6.
Killander, Fredrika, Harald Anderson, Stefan Rydén, et al.. (2007). Radiotherapy and tamoxifen after mastectomy in postmenopausal women – 20 year follow-up of the South Sweden Breast Cancer group randomised trial SSBCG II:I. European Journal of Cancer. 43(14). 2100–2108. 19 indexed citations
7.
Fernö, Mårten, Olle Stål, Thomas Hatschek, et al.. (2000). Results of two or five years of adjuvant tamoxifen correlated to steroid receptor and S-phase levels. Breast Cancer Research and Treatment. 59(1). 69–76. 66 indexed citations
8.
Nyström, Lennarth, Lars‐Gunnar Larsson, Lars Erik Rutqvist, et al.. (1995). Determination of Cause of Death Among Breast Cancer Cases in the Swedish Randomized Mammography Screening Trials: A comparison between official statistics and validation by an endpoint committee. Acta Oncologica. 34(2). 145–152. 97 indexed citations
9.
Borg, Åke, et al.. (1994). ERBB2 amplification is associated with tamoxifen resistance in steroid-receptor positive breast cancer. Cancer Letters. 81(2). 137–144. 203 indexed citations
10.
Rydén, Stefan, Mårten Fernö, Henrik Møller, et al.. (1992). Long-Term Effects of Adjuvant Tamoxifen and/or Radiotherapy: The South Sweden Breast Cancer Trial. Acta Oncologica. 31(2). 271–274. 37 indexed citations
11.
Rydén, Stefan, Mårten Fernö, Åke Borg, et al.. (1988). Prognostic significance of estrogen and progesterone receptors in stage ii breast cancer. Journal of Surgical Oncology. 37(4). 221–226. 13 indexed citations
12.
Bergqvist, Lennart, Ralf Sundberg, Stefan Rydén, & Sven‐Erik Strand. (1987). The "critical colloid dose" in studies of reticuloendothelial function.. PubMed. 28(9). 1424–9. 30 indexed citations
13.
Bergqvist, Lennart, et al.. (1987). Hepatic reticuloendothelial function in rats with various portasystemic shunts and total liver arterialization. Journal of Hepatology. 4(1). 80–85. 5 indexed citations
14.
Rydén, Stefan, et al.. (1986). Adjuvant therapy of breast cancer: Compliance and data validity in a multicenter trial. Controlled Clinical Trials. 7(4). 290–305. 12 indexed citations
15.
Tanaka, Nobutaka, et al.. (1985). A Rat Model for Sepsis in Chronic Biliary Obstruction. Acta Pathologica Microbiologica Scandinavica Series B Microbiology. 93B(1-6). 171–174. 3 indexed citations
16.
Rydén, Stefan, Lennart Bergqvist, Larsolof Hafström, et al.. (1984). Influence of a reticuloendothelial‐suppressing agent on liver tumor growth in the rat. Journal of Surgical Oncology. 26(4). 245–251. 7 indexed citations
17.
Rydén, Stefan, Lennart Bergqvist, Larsolof Hafström, & Sven‐Erik Strand. (1983). Reticuloendothelial function in normal and tumor-bearing rats. Measurements with a scintillation camera technique. European Journal of Cancer and Clinical Oncology. 19(7). 965–970. 5 indexed citations
18.
Bengmark, Stig, Larsolof Hafström, Bengt Jeppsson, et al.. (1982). Metastatic disease in the liver from colorectal cancer: An appraisal of liver surgery. World Journal of Surgery. 6(1). 61–65. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jørn Andersen Breakdown of academic impact, for papers by Jane E. Brock Breakdown of academic impact, for papers by Xiao-Ming Xie Breakdown of academic impact, for papers by R Gray Breakdown of academic impact, for papers by D Perrault Breakdown of academic impact, for papers by Jaume Capdevila Breakdown of academic impact, for papers by Johanna Wassermann Breakdown of academic impact, for papers by JN Atkins Breakdown of academic impact, for papers by Hagen Kennecke Breakdown of academic impact, for papers by P C Allgood
Rankless by CCL
2026